Skip to main content

Table 1 Demographic and clinical characteristics of study participants

From: Cut-off value for interleukin-34 as an additional potential inflammatory biomarker for estimation of slow coronary flow risk

Variables

SCF (n = 124)

NCF (n = 132)

*p

Age, years

52 ± 10

54 ± 13

0.54

Male gender, n

59 (%49)

66 (%50)

0.82

BMI, kg/m2

30.2 ± 8.1

31.7 ± 4.2

0.66

Hypertension, n

37 (%30)

42 (%32)

0.86

Diabetes mellitus, n

50 (%40)

50 (%38)

0.77

Hyperlipidemia, n

27 (%22)

32 (%24)

0.68

Cigarette smoking, n

37 (%30)

35 (%27)

0.24

Family history of CAD, n

74 (%60)

77 (%58)

0.82

Fasting glucose, mg/Dl

111 ± 34

101 ± 28

0.54

Total cholesterol, mg/dL

198 ± 42

192 ± 33

0.68

Triglycerides, mg/dL

154 ± 76

148 ± 58

0.18

HDL cholesterol, mg/dL

40 ± 12

44 ± 14

0.12

LDL cholesterol, mg/dL

168 ± 33

144 ± 28

0.16

hsCRP, mg/dL

3.8 ± 0.4

1.1 ± 0.2

0.008

IL-34, pg/mL

38.8 ± 4.4

10.3 ± 4.2

< 0.001

TIMI frame count measurements

LAD

62 ± 26

28 ± 5

< 0.001

LAD(corrected)

37 ± 16

16 ± 2

< 0.001

LCx

28 ± 10

19 ± 4

< 0.001

RCA

40 ± 22

18 ± 7

< 0.001

Mean

37 ± 11

18 ± 5

< 0.001

The length of epicardial coronary arteries

LAD,mm

168 ± 21

171 ± 18

0.86

LCx,mm

124 ± 32

121 ± 26

0.74

RCA,mm

180 ± 37

168 ± 33

0.44

Diameters of coronary arteries

LAD,mm

3.86 ± 0.46

3.48 ± 0.52

0.022

LCx,mm

3.52 ± 0.62

3.24 ± 0.72

0.046

RCA,mm

3.66 ± 0.62

3.12 ± 0.56

0.009

Coronary flow velocities

LAD,mm/s

101.7 ± 44.0

184.6 ± 57.8

< 0.001

LCx,mm/s

150.9 ± 57.6

201.7 ± 61.2

< 0.001

RCA,mm/s

167.6 ± 70.9

279.1 ± 76.4

< 0.001